nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—Nucleoside Analog—Azathioprine—systemic scleroderma	0.572	1	CiPCiCtD
Zidovudine—UGT2B7—Mycophenolic acid—systemic scleroderma	0.057	0.184	CbGbCtD
Zidovudine—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.0319	0.103	CbGbCtD
Zidovudine—ABCG2—Leflunomide—systemic scleroderma	0.0245	0.079	CbGbCtD
Zidovudine—CYP2C8—Mometasone—systemic scleroderma	0.0203	0.0653	CbGbCtD
Zidovudine—SLC22A6—Captopril—systemic scleroderma	0.0156	0.0502	CbGbCtD
Zidovudine—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0151	0.0488	CbGbCtD
Zidovudine—ALB—Captopril—systemic scleroderma	0.0133	0.0427	CbGbCtD
Zidovudine—SLC22A11—Methotrexate—systemic scleroderma	0.0121	0.0391	CbGbCtD
Zidovudine—SLC22A7—Methotrexate—systemic scleroderma	0.0116	0.0373	CbGbCtD
Zidovudine—ABCC4—Methotrexate—systemic scleroderma	0.0113	0.0364	CbGbCtD
Zidovudine—ALB—Mycophenolate mofetil—systemic scleroderma	0.0104	0.0336	CbGbCtD
Zidovudine—ABCB1—Lisinopril—systemic scleroderma	0.00927	0.0299	CbGbCtD
Zidovudine—CYP2C9—Leflunomide—systemic scleroderma	0.00911	0.0294	CbGbCtD
Zidovudine—ALB—Prednisone—systemic scleroderma	0.00835	0.0269	CbGbCtD
Zidovudine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.00807	0.026	CbGbCtD
Zidovudine—SLC22A8—Methotrexate—systemic scleroderma	0.00706	0.0227	CbGbCtD
Zidovudine—ABCB1—Captopril—systemic scleroderma	0.00694	0.0224	CbGbCtD
Zidovudine—ABCG2—Methotrexate—systemic scleroderma	0.00607	0.0196	CbGbCtD
Zidovudine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00546	0.0176	CbGbCtD
Zidovudine—CYP2C19—Prednisone—systemic scleroderma	0.00541	0.0174	CbGbCtD
Zidovudine—SLC22A6—Methotrexate—systemic scleroderma	0.00492	0.0158	CbGbCtD
Zidovudine—ABCB1—Prednisone—systemic scleroderma	0.00437	0.0141	CbGbCtD
Zidovudine—ALB—Methotrexate—systemic scleroderma	0.00419	0.0135	CbGbCtD
Zidovudine—CYP2C9—cardial valve—systemic scleroderma	0.00386	0.202	CbGeAlD
Zidovudine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00327	0.0105	CbGbCtD
Zidovudine—CYP3A4—Prednisone—systemic scleroderma	0.00262	0.00843	CbGbCtD
Zidovudine—TERT—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.00256	1	CbGdCrCtD
Zidovudine—ABCB1—Methotrexate—systemic scleroderma	0.00219	0.00706	CbGbCtD
Zidovudine—TERT—connective tissue—systemic scleroderma	0.00169	0.0883	CbGeAlD
Zidovudine—TERT—skin of body—systemic scleroderma	0.00152	0.0797	CbGeAlD
Zidovudine—SLC28A1—digestive system—systemic scleroderma	0.00124	0.0649	CbGeAlD
Zidovudine—TERT—digestive system—systemic scleroderma	0.00122	0.0638	CbGeAlD
Zidovudine—TK1—skin of body—systemic scleroderma	0.00105	0.0548	CbGeAlD
Zidovudine—TERT—lung—systemic scleroderma	0.00102	0.0532	CbGeAlD
Zidovudine—TK1—digestive system—systemic scleroderma	0.000838	0.0439	CbGeAlD
Zidovudine—TK1—tendon—systemic scleroderma	0.000797	0.0418	CbGeAlD
Zidovudine—TK1—lung—systemic scleroderma	0.000699	0.0366	CbGeAlD
Zidovudine—SLC29A2—tendon—systemic scleroderma	0.000659	0.0345	CbGeAlD
Zidovudine—UGT2B7—digestive system—systemic scleroderma	0.000468	0.0245	CbGeAlD
Zidovudine—SLC22A11—digestive system—systemic scleroderma	0.000456	0.0239	CbGeAlD
Zidovudine—SLC22A7—digestive system—systemic scleroderma	0.000445	0.0233	CbGeAlD
Zidovudine—SLC22A2—digestive system—systemic scleroderma	0.000396	0.0208	CbGeAlD
Zidovudine—ABCC5—tendon—systemic scleroderma	0.000356	0.0186	CbGeAlD
Zidovudine—ABCC5—lung—systemic scleroderma	0.000312	0.0164	CbGeAlD
Zidovudine—CYP2A6—lung—systemic scleroderma	0.00028	0.0147	CbGeAlD
Zidovudine—ABCC4—digestive system—systemic scleroderma	0.000259	0.0136	CbGeAlD
Zidovudine—ABCC4—tendon—systemic scleroderma	0.000247	0.0129	CbGeAlD
Zidovudine—ABCB1—blood vessel—systemic scleroderma	0.000244	0.0128	CbGeAlD
Zidovudine—ABCC4—lung—systemic scleroderma	0.000217	0.0113	CbGeAlD
Zidovudine—CYP2C19—digestive system—systemic scleroderma	0.000216	0.0113	CbGeAlD
Zidovudine—CYP2C9—digestive system—systemic scleroderma	0.000167	0.00876	CbGeAlD
Zidovudine—ABCG2—lung—systemic scleroderma	0.000153	0.00801	CbGeAlD
Zidovudine—CYP3A4—digestive system—systemic scleroderma	0.000128	0.00668	CbGeAlD
Zidovudine—ABCB1—digestive system—systemic scleroderma	9.03e-05	0.00473	CbGeAlD
Zidovudine—ABCB1—lung—systemic scleroderma	7.54e-05	0.00395	CbGeAlD
Zidovudine—Constipation—Leflunomide—systemic scleroderma	7.16e-05	0.000744	CcSEcCtD
Zidovudine—Anaemia—Mycophenolate mofetil—systemic scleroderma	7.14e-05	0.000741	CcSEcCtD
Zidovudine—Dyspnoea—Mycophenolic acid—systemic scleroderma	7.12e-05	0.00074	CcSEcCtD
Zidovudine—Somnolence—Mycophenolic acid—systemic scleroderma	7.1e-05	0.000738	CcSEcCtD
Zidovudine—Shock—Lisinopril—systemic scleroderma	7.08e-05	0.000735	CcSEcCtD
Zidovudine—Angioedema—Mycophenolate mofetil—systemic scleroderma	7.06e-05	0.000733	CcSEcCtD
Zidovudine—Thrombocytopenia—Lisinopril—systemic scleroderma	7.05e-05	0.000732	CcSEcCtD
Zidovudine—Dyspepsia—Mycophenolic acid—systemic scleroderma	7.03e-05	0.00073	CcSEcCtD
Zidovudine—Neutropenia—Prednisone—systemic scleroderma	7.03e-05	0.00073	CcSEcCtD
Zidovudine—Abdominal pain—Azathioprine—systemic scleroderma	7.01e-05	0.000728	CcSEcCtD
Zidovudine—Body temperature increased—Azathioprine—systemic scleroderma	7.01e-05	0.000728	CcSEcCtD
Zidovudine—Skin disorder—Lisinopril—systemic scleroderma	6.99e-05	0.000726	CcSEcCtD
Zidovudine—Malaise—Mycophenolate mofetil—systemic scleroderma	6.97e-05	0.000723	CcSEcCtD
Zidovudine—Hyperhidrosis—Lisinopril—systemic scleroderma	6.96e-05	0.000722	CcSEcCtD
Zidovudine—Diarrhoea—Captopril—systemic scleroderma	6.95e-05	0.000722	CcSEcCtD
Zidovudine—Decreased appetite—Mycophenolic acid—systemic scleroderma	6.94e-05	0.000721	CcSEcCtD
Zidovudine—Vertigo—Mycophenolate mofetil—systemic scleroderma	6.94e-05	0.000721	CcSEcCtD
Zidovudine—Irritability—Methotrexate—systemic scleroderma	6.94e-05	0.00072	CcSEcCtD
Zidovudine—Syncope—Mycophenolate mofetil—systemic scleroderma	6.93e-05	0.000719	CcSEcCtD
Zidovudine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	6.92e-05	0.000718	CcSEcCtD
Zidovudine—Feeling abnormal—Leflunomide—systemic scleroderma	6.9e-05	0.000717	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	6.9e-05	0.000716	CcSEcCtD
Zidovudine—Fatigue—Mycophenolic acid—systemic scleroderma	6.89e-05	0.000715	CcSEcCtD
Zidovudine—Mood swings—Methotrexate—systemic scleroderma	6.88e-05	0.000715	CcSEcCtD
Zidovudine—Nausea—Mometasone—systemic scleroderma	6.87e-05	0.000714	CcSEcCtD
Zidovudine—Anorexia—Lisinopril—systemic scleroderma	6.86e-05	0.000712	CcSEcCtD
Zidovudine—Gastrointestinal pain—Leflunomide—systemic scleroderma	6.85e-05	0.000711	CcSEcCtD
Zidovudine—Pain—Mycophenolic acid—systemic scleroderma	6.83e-05	0.000709	CcSEcCtD
Zidovudine—Constipation—Mycophenolic acid—systemic scleroderma	6.83e-05	0.000709	CcSEcCtD
Zidovudine—Weight decreased—Prednisone—systemic scleroderma	6.8e-05	0.000706	CcSEcCtD
Zidovudine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	6.79e-05	0.000705	CcSEcCtD
Zidovudine—Cough—Mycophenolate mofetil—systemic scleroderma	6.74e-05	0.0007	CcSEcCtD
Zidovudine—Dizziness—Captopril—systemic scleroderma	6.72e-05	0.000698	CcSEcCtD
Zidovudine—Convulsion—Mycophenolate mofetil—systemic scleroderma	6.69e-05	0.000695	CcSEcCtD
Zidovudine—Urticaria—Leflunomide—systemic scleroderma	6.65e-05	0.000691	CcSEcCtD
Zidovudine—Body temperature increased—Leflunomide—systemic scleroderma	6.62e-05	0.000687	CcSEcCtD
Zidovudine—Abdominal pain—Leflunomide—systemic scleroderma	6.62e-05	0.000687	CcSEcCtD
Zidovudine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	6.58e-05	0.000684	CcSEcCtD
Zidovudine—Chest pain—Mycophenolate mofetil—systemic scleroderma	6.58e-05	0.000683	CcSEcCtD
Zidovudine—Myalgia—Mycophenolate mofetil—systemic scleroderma	6.58e-05	0.000683	CcSEcCtD
Zidovudine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	6.58e-05	0.000683	CcSEcCtD
Zidovudine—Neuropathy peripheral—Prednisone—systemic scleroderma	6.57e-05	0.000682	CcSEcCtD
Zidovudine—Breast disorder—Methotrexate—systemic scleroderma	6.57e-05	0.000682	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	6.56e-05	0.000681	CcSEcCtD
Zidovudine—Anxiety—Mycophenolate mofetil—systemic scleroderma	6.55e-05	0.000681	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	6.54e-05	0.00068	CcSEcCtD
Zidovudine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	6.53e-05	0.000678	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	6.53e-05	0.000678	CcSEcCtD
Zidovudine—Insomnia—Lisinopril—systemic scleroderma	6.51e-05	0.000676	CcSEcCtD
Zidovudine—Discomfort—Mycophenolate mofetil—systemic scleroderma	6.5e-05	0.000675	CcSEcCtD
Zidovudine—Paraesthesia—Lisinopril—systemic scleroderma	6.46e-05	0.000671	CcSEcCtD
Zidovudine—Vomiting—Captopril—systemic scleroderma	6.46e-05	0.000671	CcSEcCtD
Zidovudine—Dyspnoea—Lisinopril—systemic scleroderma	6.42e-05	0.000666	CcSEcCtD
Zidovudine—Rash—Captopril—systemic scleroderma	6.41e-05	0.000665	CcSEcCtD
Zidovudine—Dermatitis—Captopril—systemic scleroderma	6.4e-05	0.000665	CcSEcCtD
Zidovudine—Somnolence—Lisinopril—systemic scleroderma	6.4e-05	0.000664	CcSEcCtD
Zidovudine—Headache—Captopril—systemic scleroderma	6.37e-05	0.000661	CcSEcCtD
Zidovudine—Confusional state—Mycophenolate mofetil—systemic scleroderma	6.36e-05	0.00066	CcSEcCtD
Zidovudine—Dyspepsia—Lisinopril—systemic scleroderma	6.33e-05	0.000658	CcSEcCtD
Zidovudine—Body temperature increased—Mycophenolic acid—systemic scleroderma	6.32e-05	0.000656	CcSEcCtD
Zidovudine—Abdominal pain—Mycophenolic acid—systemic scleroderma	6.32e-05	0.000656	CcSEcCtD
Zidovudine—Oedema—Mycophenolate mofetil—systemic scleroderma	6.3e-05	0.000655	CcSEcCtD
Zidovudine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	6.3e-05	0.000655	CcSEcCtD
Zidovudine—Decreased appetite—Lisinopril—systemic scleroderma	6.26e-05	0.00065	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	6.21e-05	0.000645	CcSEcCtD
Zidovudine—Fatigue—Lisinopril—systemic scleroderma	6.2e-05	0.000644	CcSEcCtD
Zidovudine—Shock—Mycophenolate mofetil—systemic scleroderma	6.2e-05	0.000644	CcSEcCtD
Zidovudine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	6.18e-05	0.000642	CcSEcCtD
Zidovudine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	6.17e-05	0.000641	CcSEcCtD
Zidovudine—Pancreatitis—Methotrexate—systemic scleroderma	6.16e-05	0.000639	CcSEcCtD
Zidovudine—Pain—Lisinopril—systemic scleroderma	6.15e-05	0.000639	CcSEcCtD
Zidovudine—Constipation—Lisinopril—systemic scleroderma	6.15e-05	0.000639	CcSEcCtD
Zidovudine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	6.12e-05	0.000636	CcSEcCtD
Zidovudine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	6.1e-05	0.000633	CcSEcCtD
Zidovudine—Diarrhoea—Azathioprine—systemic scleroderma	6.07e-05	0.00063	CcSEcCtD
Zidovudine—Nausea—Captopril—systemic scleroderma	6.04e-05	0.000627	CcSEcCtD
Zidovudine—Anorexia—Mycophenolate mofetil—systemic scleroderma	6.01e-05	0.000624	CcSEcCtD
Zidovudine—Asthenia—Leflunomide—systemic scleroderma	6.01e-05	0.000624	CcSEcCtD
Zidovudine—Pancytopenia—Methotrexate—systemic scleroderma	5.96e-05	0.000619	CcSEcCtD
Zidovudine—Feeling abnormal—Lisinopril—systemic scleroderma	5.93e-05	0.000616	CcSEcCtD
Zidovudine—Pruritus—Leflunomide—systemic scleroderma	5.92e-05	0.000615	CcSEcCtD
Zidovudine—Connective tissue disorder—Prednisone—systemic scleroderma	5.91e-05	0.000614	CcSEcCtD
Zidovudine—Gastrointestinal pain—Lisinopril—systemic scleroderma	5.88e-05	0.000611	CcSEcCtD
Zidovudine—Dysuria—Methotrexate—systemic scleroderma	5.87e-05	0.00061	CcSEcCtD
Zidovudine—Neutropenia—Methotrexate—systemic scleroderma	5.87e-05	0.00061	CcSEcCtD
Zidovudine—Dizziness—Azathioprine—systemic scleroderma	5.86e-05	0.000609	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	5.74e-05	0.000597	CcSEcCtD
Zidovudine—Asthenia—Mycophenolic acid—systemic scleroderma	5.73e-05	0.000595	CcSEcCtD
Zidovudine—Diarrhoea—Leflunomide—systemic scleroderma	5.73e-05	0.000595	CcSEcCtD
Zidovudine—Urticaria—Lisinopril—systemic scleroderma	5.72e-05	0.000594	CcSEcCtD
Zidovudine—Insomnia—Mycophenolate mofetil—systemic scleroderma	5.7e-05	0.000592	CcSEcCtD
Zidovudine—Abdominal pain—Lisinopril—systemic scleroderma	5.69e-05	0.000591	CcSEcCtD
Zidovudine—Body temperature increased—Lisinopril—systemic scleroderma	5.69e-05	0.000591	CcSEcCtD
Zidovudine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	5.66e-05	0.000588	CcSEcCtD
Zidovudine—Pruritus—Mycophenolic acid—systemic scleroderma	5.65e-05	0.000587	CcSEcCtD
Zidovudine—Vomiting—Azathioprine—systemic scleroderma	5.64e-05	0.000586	CcSEcCtD
Zidovudine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	5.62e-05	0.000584	CcSEcCtD
Zidovudine—Somnolence—Mycophenolate mofetil—systemic scleroderma	5.61e-05	0.000582	CcSEcCtD
Zidovudine—Rash—Azathioprine—systemic scleroderma	5.59e-05	0.000581	CcSEcCtD
Zidovudine—Dermatitis—Azathioprine—systemic scleroderma	5.59e-05	0.00058	CcSEcCtD
Zidovudine—Headache—Azathioprine—systemic scleroderma	5.56e-05	0.000577	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	5.55e-05	0.000577	CcSEcCtD
Zidovudine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	5.55e-05	0.000576	CcSEcCtD
Zidovudine—Dizziness—Leflunomide—systemic scleroderma	5.54e-05	0.000575	CcSEcCtD
Zidovudine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	5.48e-05	0.000569	CcSEcCtD
Zidovudine—Diarrhoea—Mycophenolic acid—systemic scleroderma	5.47e-05	0.000568	CcSEcCtD
Zidovudine—Stomatitis—Methotrexate—systemic scleroderma	5.46e-05	0.000567	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	5.44e-05	0.000565	CcSEcCtD
Zidovudine—Pain—Mycophenolate mofetil—systemic scleroderma	5.39e-05	0.00056	CcSEcCtD
Zidovudine—Constipation—Mycophenolate mofetil—systemic scleroderma	5.39e-05	0.00056	CcSEcCtD
Zidovudine—Sweating—Methotrexate—systemic scleroderma	5.37e-05	0.000558	CcSEcCtD
Zidovudine—Haematuria—Methotrexate—systemic scleroderma	5.34e-05	0.000555	CcSEcCtD
Zidovudine—Vomiting—Leflunomide—systemic scleroderma	5.32e-05	0.000553	CcSEcCtD
Zidovudine—Hepatobiliary disease—Methotrexate—systemic scleroderma	5.3e-05	0.00055	CcSEcCtD
Zidovudine—Dizziness—Mycophenolic acid—systemic scleroderma	5.28e-05	0.000549	CcSEcCtD
Zidovudine—Epistaxis—Methotrexate—systemic scleroderma	5.28e-05	0.000549	CcSEcCtD
Zidovudine—Rash—Leflunomide—systemic scleroderma	5.28e-05	0.000548	CcSEcCtD
Zidovudine—Dermatitis—Leflunomide—systemic scleroderma	5.28e-05	0.000548	CcSEcCtD
Zidovudine—Mental disorder—Prednisone—systemic scleroderma	5.27e-05	0.000547	CcSEcCtD
Zidovudine—Nausea—Azathioprine—systemic scleroderma	5.27e-05	0.000547	CcSEcCtD
Zidovudine—Headache—Leflunomide—systemic scleroderma	5.25e-05	0.000545	CcSEcCtD
Zidovudine—Erythema—Prednisone—systemic scleroderma	5.24e-05	0.000544	CcSEcCtD
Zidovudine—Malnutrition—Prednisone—systemic scleroderma	5.24e-05	0.000544	CcSEcCtD
Zidovudine—Agranulocytosis—Methotrexate—systemic scleroderma	5.23e-05	0.000543	CcSEcCtD
Zidovudine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	5.2e-05	0.00054	CcSEcCtD
Zidovudine—Asthenia—Lisinopril—systemic scleroderma	5.16e-05	0.000536	CcSEcCtD
Zidovudine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	5.16e-05	0.000535	CcSEcCtD
Zidovudine—Pruritus—Lisinopril—systemic scleroderma	5.09e-05	0.000529	CcSEcCtD
Zidovudine—Vomiting—Mycophenolic acid—systemic scleroderma	5.08e-05	0.000528	CcSEcCtD
Zidovudine—Rash—Mycophenolic acid—systemic scleroderma	5.04e-05	0.000523	CcSEcCtD
Zidovudine—Dermatitis—Mycophenolic acid—systemic scleroderma	5.03e-05	0.000523	CcSEcCtD
Zidovudine—Hepatitis—Methotrexate—systemic scleroderma	5.03e-05	0.000522	CcSEcCtD
Zidovudine—Urticaria—Mycophenolate mofetil—systemic scleroderma	5.01e-05	0.00052	CcSEcCtD
Zidovudine—Headache—Mycophenolic acid—systemic scleroderma	5e-05	0.00052	CcSEcCtD
Zidovudine—Pharyngitis—Methotrexate—systemic scleroderma	4.99e-05	0.000518	CcSEcCtD
Zidovudine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	4.98e-05	0.000518	CcSEcCtD
Zidovudine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	4.98e-05	0.000518	CcSEcCtD
Zidovudine—Nausea—Leflunomide—systemic scleroderma	4.97e-05	0.000517	CcSEcCtD
Zidovudine—Urinary tract disorder—Methotrexate—systemic scleroderma	4.96e-05	0.000516	CcSEcCtD
Zidovudine—Urethral disorder—Methotrexate—systemic scleroderma	4.93e-05	0.000512	CcSEcCtD
Zidovudine—Diarrhoea—Lisinopril—systemic scleroderma	4.92e-05	0.000511	CcSEcCtD
Zidovudine—Ill-defined disorder—Prednisone—systemic scleroderma	4.86e-05	0.000505	CcSEcCtD
Zidovudine—Anaemia—Prednisone—systemic scleroderma	4.84e-05	0.000503	CcSEcCtD
Zidovudine—Angioedema—Prednisone—systemic scleroderma	4.78e-05	0.000497	CcSEcCtD
Zidovudine—Dizziness—Lisinopril—systemic scleroderma	4.76e-05	0.000494	CcSEcCtD
Zidovudine—Erythema multiforme—Methotrexate—systemic scleroderma	4.75e-05	0.000494	CcSEcCtD
Zidovudine—Nausea—Mycophenolic acid—systemic scleroderma	4.75e-05	0.000493	CcSEcCtD
Zidovudine—Malaise—Prednisone—systemic scleroderma	4.72e-05	0.00049	CcSEcCtD
Zidovudine—Vertigo—Prednisone—systemic scleroderma	4.7e-05	0.000489	CcSEcCtD
Zidovudine—Syncope—Prednisone—systemic scleroderma	4.7e-05	0.000488	CcSEcCtD
Zidovudine—Cardiac disorder—Methotrexate—systemic scleroderma	4.67e-05	0.000485	CcSEcCtD
Zidovudine—Loss of consciousness—Prednisone—systemic scleroderma	4.6e-05	0.000478	CcSEcCtD
Zidovudine—Vomiting—Lisinopril—systemic scleroderma	4.58e-05	0.000475	CcSEcCtD
Zidovudine—Rash—Lisinopril—systemic scleroderma	4.54e-05	0.000471	CcSEcCtD
Zidovudine—Convulsion—Prednisone—systemic scleroderma	4.54e-05	0.000471	CcSEcCtD
Zidovudine—Dermatitis—Lisinopril—systemic scleroderma	4.53e-05	0.000471	CcSEcCtD
Zidovudine—Mediastinal disorder—Methotrexate—systemic scleroderma	4.53e-05	0.000471	CcSEcCtD
Zidovudine—Asthenia—Mycophenolate mofetil—systemic scleroderma	4.52e-05	0.00047	CcSEcCtD
Zidovudine—Chills—Methotrexate—systemic scleroderma	4.51e-05	0.000468	CcSEcCtD
Zidovudine—Headache—Lisinopril—systemic scleroderma	4.51e-05	0.000468	CcSEcCtD
Zidovudine—Pruritus—Mycophenolate mofetil—systemic scleroderma	4.46e-05	0.000463	CcSEcCtD
Zidovudine—Myalgia—Prednisone—systemic scleroderma	4.46e-05	0.000463	CcSEcCtD
Zidovudine—Arthralgia—Prednisone—systemic scleroderma	4.46e-05	0.000463	CcSEcCtD
Zidovudine—Anxiety—Prednisone—systemic scleroderma	4.44e-05	0.000461	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	4.43e-05	0.00046	CcSEcCtD
Zidovudine—Discomfort—Prednisone—systemic scleroderma	4.4e-05	0.000457	CcSEcCtD
Zidovudine—Mental disorder—Methotrexate—systemic scleroderma	4.4e-05	0.000457	CcSEcCtD
Zidovudine—Erythema—Methotrexate—systemic scleroderma	4.38e-05	0.000454	CcSEcCtD
Zidovudine—Malnutrition—Methotrexate—systemic scleroderma	4.38e-05	0.000454	CcSEcCtD
Zidovudine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	4.31e-05	0.000448	CcSEcCtD
Zidovudine—Dysgeusia—Methotrexate—systemic scleroderma	4.29e-05	0.000445	CcSEcCtD
Zidovudine—Nausea—Lisinopril—systemic scleroderma	4.27e-05	0.000444	CcSEcCtD
Zidovudine—Anaphylactic shock—Prednisone—systemic scleroderma	4.27e-05	0.000444	CcSEcCtD
Zidovudine—Oedema—Prednisone—systemic scleroderma	4.27e-05	0.000444	CcSEcCtD
Zidovudine—Back pain—Methotrexate—systemic scleroderma	4.23e-05	0.00044	CcSEcCtD
Zidovudine—Shock—Prednisone—systemic scleroderma	4.2e-05	0.000437	CcSEcCtD
Zidovudine—Nervous system disorder—Prednisone—systemic scleroderma	4.19e-05	0.000435	CcSEcCtD
Zidovudine—Dizziness—Mycophenolate mofetil—systemic scleroderma	4.17e-05	0.000433	CcSEcCtD
Zidovudine—Skin disorder—Prednisone—systemic scleroderma	4.15e-05	0.000431	CcSEcCtD
Zidovudine—Hyperhidrosis—Prednisone—systemic scleroderma	4.13e-05	0.000429	CcSEcCtD
Zidovudine—Anorexia—Prednisone—systemic scleroderma	4.07e-05	0.000423	CcSEcCtD
Zidovudine—Ill-defined disorder—Methotrexate—systemic scleroderma	4.06e-05	0.000422	CcSEcCtD
Zidovudine—Anaemia—Methotrexate—systemic scleroderma	4.04e-05	0.00042	CcSEcCtD
Zidovudine—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.01e-05	0.000416	CcSEcCtD
Zidovudine—Rash—Mycophenolate mofetil—systemic scleroderma	3.98e-05	0.000413	CcSEcCtD
Zidovudine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	3.97e-05	0.000412	CcSEcCtD
Zidovudine—Headache—Mycophenolate mofetil—systemic scleroderma	3.95e-05	0.00041	CcSEcCtD
Zidovudine—Malaise—Methotrexate—systemic scleroderma	3.95e-05	0.00041	CcSEcCtD
Zidovudine—Vertigo—Methotrexate—systemic scleroderma	3.93e-05	0.000408	CcSEcCtD
Zidovudine—Leukopenia—Methotrexate—systemic scleroderma	3.92e-05	0.000407	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	3.89e-05	0.000404	CcSEcCtD
Zidovudine—Insomnia—Prednisone—systemic scleroderma	3.87e-05	0.000401	CcSEcCtD
Zidovudine—Paraesthesia—Prednisone—systemic scleroderma	3.84e-05	0.000399	CcSEcCtD
Zidovudine—Cough—Methotrexate—systemic scleroderma	3.82e-05	0.000397	CcSEcCtD
Zidovudine—Convulsion—Methotrexate—systemic scleroderma	3.79e-05	0.000394	CcSEcCtD
Zidovudine—Dyspepsia—Prednisone—systemic scleroderma	3.76e-05	0.000391	CcSEcCtD
Zidovudine—Nausea—Mycophenolate mofetil—systemic scleroderma	3.75e-05	0.000389	CcSEcCtD
Zidovudine—Arthralgia—Methotrexate—systemic scleroderma	3.73e-05	0.000387	CcSEcCtD
Zidovudine—Myalgia—Methotrexate—systemic scleroderma	3.73e-05	0.000387	CcSEcCtD
Zidovudine—Chest pain—Methotrexate—systemic scleroderma	3.73e-05	0.000387	CcSEcCtD
Zidovudine—Decreased appetite—Prednisone—systemic scleroderma	3.72e-05	0.000386	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	3.7e-05	0.000384	CcSEcCtD
Zidovudine—Fatigue—Prednisone—systemic scleroderma	3.68e-05	0.000383	CcSEcCtD
Zidovudine—Discomfort—Methotrexate—systemic scleroderma	3.68e-05	0.000382	CcSEcCtD
Zidovudine—Constipation—Prednisone—systemic scleroderma	3.65e-05	0.00038	CcSEcCtD
Zidovudine—Confusional state—Methotrexate—systemic scleroderma	3.6e-05	0.000374	CcSEcCtD
Zidovudine—Anaphylactic shock—Methotrexate—systemic scleroderma	3.57e-05	0.000371	CcSEcCtD
Zidovudine—Feeling abnormal—Prednisone—systemic scleroderma	3.52e-05	0.000366	CcSEcCtD
Zidovudine—Nervous system disorder—Methotrexate—systemic scleroderma	3.5e-05	0.000364	CcSEcCtD
Zidovudine—Thrombocytopenia—Methotrexate—systemic scleroderma	3.5e-05	0.000363	CcSEcCtD
Zidovudine—Gastrointestinal pain—Prednisone—systemic scleroderma	3.49e-05	0.000363	CcSEcCtD
Zidovudine—Skin disorder—Methotrexate—systemic scleroderma	3.47e-05	0.00036	CcSEcCtD
Zidovudine—Hyperhidrosis—Methotrexate—systemic scleroderma	3.45e-05	0.000359	CcSEcCtD
Zidovudine—Anorexia—Methotrexate—systemic scleroderma	3.4e-05	0.000354	CcSEcCtD
Zidovudine—Urticaria—Prednisone—systemic scleroderma	3.4e-05	0.000353	CcSEcCtD
Zidovudine—Body temperature increased—Prednisone—systemic scleroderma	3.38e-05	0.000351	CcSEcCtD
Zidovudine—Abdominal pain—Prednisone—systemic scleroderma	3.38e-05	0.000351	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.25e-05	0.000338	CcSEcCtD
Zidovudine—Insomnia—Methotrexate—systemic scleroderma	3.23e-05	0.000335	CcSEcCtD
Zidovudine—Paraesthesia—Methotrexate—systemic scleroderma	3.21e-05	0.000333	CcSEcCtD
Zidovudine—Dyspnoea—Methotrexate—systemic scleroderma	3.18e-05	0.000331	CcSEcCtD
Zidovudine—Somnolence—Methotrexate—systemic scleroderma	3.18e-05	0.00033	CcSEcCtD
Zidovudine—Dyspepsia—Methotrexate—systemic scleroderma	3.14e-05	0.000326	CcSEcCtD
Zidovudine—Decreased appetite—Methotrexate—systemic scleroderma	3.1e-05	0.000322	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.08e-05	0.00032	CcSEcCtD
Zidovudine—Fatigue—Methotrexate—systemic scleroderma	3.08e-05	0.00032	CcSEcCtD
Zidovudine—Asthenia—Prednisone—systemic scleroderma	3.07e-05	0.000318	CcSEcCtD
Zidovudine—Pain—Methotrexate—systemic scleroderma	3.05e-05	0.000317	CcSEcCtD
Zidovudine—Pruritus—Prednisone—systemic scleroderma	3.02e-05	0.000314	CcSEcCtD
Zidovudine—Feeling abnormal—Methotrexate—systemic scleroderma	2.94e-05	0.000306	CcSEcCtD
Zidovudine—Diarrhoea—Prednisone—systemic scleroderma	2.92e-05	0.000304	CcSEcCtD
Zidovudine—Gastrointestinal pain—Methotrexate—systemic scleroderma	2.92e-05	0.000303	CcSEcCtD
Zidovudine—Urticaria—Methotrexate—systemic scleroderma	2.84e-05	0.000295	CcSEcCtD
Zidovudine—Dizziness—Prednisone—systemic scleroderma	2.83e-05	0.000293	CcSEcCtD
Zidovudine—Abdominal pain—Methotrexate—systemic scleroderma	2.82e-05	0.000293	CcSEcCtD
Zidovudine—Body temperature increased—Methotrexate—systemic scleroderma	2.82e-05	0.000293	CcSEcCtD
Zidovudine—Vomiting—Prednisone—systemic scleroderma	2.72e-05	0.000282	CcSEcCtD
Zidovudine—Rash—Prednisone—systemic scleroderma	2.69e-05	0.00028	CcSEcCtD
Zidovudine—Dermatitis—Prednisone—systemic scleroderma	2.69e-05	0.00028	CcSEcCtD
Zidovudine—Headache—Prednisone—systemic scleroderma	2.68e-05	0.000278	CcSEcCtD
Zidovudine—Asthenia—Methotrexate—systemic scleroderma	2.56e-05	0.000266	CcSEcCtD
Zidovudine—Nausea—Prednisone—systemic scleroderma	2.54e-05	0.000264	CcSEcCtD
Zidovudine—Pruritus—Methotrexate—systemic scleroderma	2.53e-05	0.000262	CcSEcCtD
Zidovudine—Diarrhoea—Methotrexate—systemic scleroderma	2.44e-05	0.000254	CcSEcCtD
Zidovudine—Dizziness—Methotrexate—systemic scleroderma	2.36e-05	0.000245	CcSEcCtD
Zidovudine—Vomiting—Methotrexate—systemic scleroderma	2.27e-05	0.000236	CcSEcCtD
Zidovudine—Rash—Methotrexate—systemic scleroderma	2.25e-05	0.000234	CcSEcCtD
Zidovudine—Dermatitis—Methotrexate—systemic scleroderma	2.25e-05	0.000234	CcSEcCtD
Zidovudine—Headache—Methotrexate—systemic scleroderma	2.24e-05	0.000232	CcSEcCtD
Zidovudine—Nausea—Methotrexate—systemic scleroderma	2.12e-05	0.00022	CcSEcCtD
